Folinis 75IU Inj. 1`s
Folinis 75IU Injection contains menotrophin, a human menopausal gonadotropin that provides follicle stimulating hormone and luteinizing hormone to stimulate ovulation in women and sperm production in men. Buy Folinis 75IU Injection at PakMeds with a valid prescription for genuine Bristol Myers Biotech Pakistan stock.
Overview
Doctors prescribe it as part of a supervised fertility treatment protocol.
Manufacturer | Bristol Myers Biotech Pakistan |
|---|---|
Active Ingredient(s) | Menotrophin (Human Menopausal Gonadotropin) |
Strength | 75IU |
Pack Size | 1 vial |
Prescription Required | Yes |
Generic Name(s) | Menotrophin, hMG |
Folinis 75IU Injection Ingredients and Usage
Folinis 75IU Injection contains menotrophin, a combination of follicle stimulating hormone and luteinizing hormone belonging to the gonadotropin drug class. Doctors prescribe it to stimulate ovarian follicle development and ovulation in women undergoing fertility treatment.
Folinis 75IU Injection is often combined with human chorionic gonadotropin later in the treatment cycle to trigger final egg maturation. It is also used to stimulate sperm production in men with certain types of infertility. Treatment is closely supervised by a fertility specialist throughout the cycle.
How Does Folinis 75IU Injection Work?
Folinis 75IU Injection provides follicle stimulating hormone, which binds to receptors in the ovary to promote the growth and maturation of ovarian follicles containing eggs. It also provides luteinizing hormone, which supports proper hormone release from the developing follicle.
By supplying both hormones together, Folinis 75IU Injection replicates the natural signals needed for ovulation, particularly in women who do not produce enough of their own luteinizing hormone. In men, the same hormone combination supports the testicular signaling needed for sperm production.
Folinis 75IU Injection Side Effects
Folinis 75IU Injection commonly causes mild hormonal and injection site side effects.
Headache
Mild stomach pain or bloating
Redness or pain at the injection site
Breast tenderness
Dizziness
Acne
Weight gain
Warnings
Folinis 75IU Injection can cause ovarian hyperstimulation syndrome, a serious condition involving enlarged ovaries, abdominal pain, and fluid accumulation; seek immediate medical attention if these symptoms occur.
The medicine increases the risk of multiple pregnancy, including twins or higher order multiples, which carries additional maternal and fetal risks.
Folinis 75IU Injection is not recommended for women whose ovaries no longer produce eggs, such as those with primary ovarian failure.
Avoid use in patients with abnormal uterine or vaginal bleeding of unknown cause, or with cancer of the breast, uterus, or ovary.
Inform the doctor of any thyroid or adrenal gland problems before starting treatment, since these should be evaluated and managed first.
Folinis 75IU Injection is contraindicated during pregnancy; a pregnancy test should confirm the patient is not already pregnant before starting treatment.
Avoid alcohol during treatment, and avoid driving if dizziness occurs after the injection.
Folinis 75IU Injection Storage Conditions
Store Folinis 75IU Injection as a lyophilized powder at room temperature between 3°C and 25°C, protected from light, or refrigerated according to the manufacturer's instructions. Keep the vial in its original packaging until immediately before reconstitution. Store this medicine out of reach of children and administer only as directed by a healthcare professional.
Customer Reviews
No reviews yet. Be the first to review this product!
Login to write a review
